Literature DB >> 2913051

Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia.

Y Morel1, J André, B Uring-Lambert, G Hauptmann, H Bétuel, M Tossi, M G Forest, M David, J Bertrand, W L Miller.   

Abstract

Congenital adrenal hyperplasia (CAH) is caused by disorders of the P450c21B gene, which, with the P450c21A pseudogene, lies in the HLA locus on chromosome 6. The near identity of nucleotide sequences and endonuclease cleavage sites in these A and B loci makes genetic analysis of this disease difficult. We used a genomic DNA probe that detects the P450c21 genes (A pseudogene, 3.2 kb; B gene, 3.7 kb in Taq I digests) and the 3' flanking DNA not detected with cDNA probes (A pseudogene, 2.4 kb; B gene, 2.5 kb) to examine Southern blots of genomic DNA from 68 patients and 165 unaffected family members in 57 families with CAH. Of 116 CAH-bearing chromosomes, 114 could be sorted into five easily distinguished haplotypes based on blots of DNA digested with Taq I and Bgl II. Haplotype I (76 of 116, 65.6%) was indistinguishable from normal and therefore bore very small lesions, presumably point mutations. Haplotype II (4 of 116, 3.4%) and haplotype III (8 of 116, 6.9%) had deletions and duplications of the P450c21A pseudogene but had structurally intact P450c21B genes presumably bearing point mutations; point mutation thus was the genetic defect in 88 of 116 chromosomes (75.9%). Haplotypes IV and V lack the 3.7-kb Taq I band normally associated with the P450c21B gene. Haplotype IV (13 of 116, 11.2%) retains all other bands, indicating that the P450c21B gene has undergone a gene conversion event, so that it is now also associated with a 3.2-kb band. Haplotype V (13 of 116, 11.2%) lacks the 2.4-kb Taq I fragment and the 12-kb Bgl II fragments normally associated with the P450c21A pseudogene, as well as lacking the 3.7-kb Taq I fragment, indicating deletion of approximately 30 kb of DNA, resulting in a single hybrid P450c21A/B gene. Most (114 of 116, 98%) CAH alleles thus can easily be classified with this new probing strategy, eliminating many ambiguities resulting from probing with cDNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2913051      PMCID: PMC303711          DOI: 10.1172/JCI113914

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Coupling of HLA-A3,Cw6,Bw47,DR7 and a normal CA21HB steroid 21-hydroxylase gene in the Old Order Amish.

Authors:  P A Donohoue; C Van Dop; C J Migeon; R H McLean; W B Bias
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

2.  Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency.

Authors:  Y Higashi; A Tanae; H Inoue; Y Fujii-Kuriyama
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis.

Authors:  I Dunham; C A Sargent; J Trowsdale; R D Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Synteny mapping of the genes for 21 steroid hydroxylase, alpha A crystallin, and class I bovine leukocyte antigen in cattle.

Authors:  L C Skow; J E Womack; J M Petresh; W L Miller
Journal:  DNA       Date:  1988-04

Review 5.  Gene conversions, deletions, and polymorphisms in congenital adrenal hyperplasia.

Authors:  W L Miller
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

6.  The study of a French family with two duplicated C4A haplotypes.

Authors:  C M Giles; B Uring-Lambert; W Boksch; M Braun; J Goetz; R Neumann; G Mauff; G Hauptmann
Journal:  Hum Genet       Date:  1987-12       Impact factor: 4.132

7.  Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1.

Authors:  P W Speiser; M I New; P C White
Journal:  N Engl J Med       Date:  1988-07-07       Impact factor: 91.245

8.  Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA.

Authors:  C Wong; C E Dowling; R K Saiki; R G Higuchi; H A Erlich; H H Kazazian
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

9.  Gene conversion-like events cause steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Authors:  F Harada; A Kimura; T Iwanaga; K Shimozawa; J Yata; T Sasazuki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

10.  Mutation in the CYP21B gene (Ile-172----Asn) causes steroid 21-hydroxylase deficiency.

Authors:  M Amor; K L Parker; H Globerman; M I New; P C White
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  26 in total

Review 1.  An overview of molecular diagnosis of steroid 21-hydroxylase deficiency.

Authors:  C E Keegan; A A Killeen
Journal:  J Mol Diagn       Date:  2001-05       Impact factor: 5.568

2.  Characterisation of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene.

Authors:  A Bobba; A Iolascon; S Giannattasio; M Albrizio; A Sinisi; F Prisco; F Schettini; E Marra
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

3.  HLADR5 and C4BQO high frequency and antinuclear antibodies positivity in patients with 21 hydroxylase deficiency from Campania region.

Authors:  F Parlato; G Pisano; G Misiano; E Cosentini; C Cacciapuoti; M R Cavalcanti; M Brai; A Bellastella
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

4.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P W Speiser; J Dupont; D Zhu; J Serrat; M Buegeleisen; M T Tusie-Luna; M Lesser; M I New; P C White
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Defining DNA diagnostic tests appropriate or standard clinical care.

Authors:  R V Lebo; G Cunningham; M J Simons; L J Shapiro
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

6.  Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency.

Authors:  E Mornet; P Crété; F Kuttenn; M C Raux-Demay; J Boué; P C White; A Boué
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

7.  Late-onset congenital adrenal hyperplasia in a group of hyperandrogenic women.

Authors:  D K Hassíakos; J P Toner; G S Jones; H W Jones
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

8.  Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus.

Authors:  Y Morel; J Bristow; S E Gitelman; W L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 9.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

10.  Substitution of Ile-172 to Asn in the steroid 21-hydroxylase B (P450c21B) gene in a Finnish patient with the simple virilizing form of congenital adrenal hyperplasia.

Authors:  J Partanen; R D Campbell
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.